Brief: Viveve Announces Completion Of U.S. Pursuit Trial For Female Stress Urinary Incontinence
15/12/2022 15:12
Dec 15 (Reuters) - Viveve Medical Inc VIVE.O :
* VIVEVE ANNOUNCES COMPLETION OF PIVOTAL U.S. PURSUIT TRIAL
FOR
FEMALE STRESS URINARY INCONTINENCE WITH FINAL 12-MONTH FOLLOW-UP
VISITS CONCLUDED
* VIVEVE MEDICAL INC - TOPLINE RESULTS OF THE 12-MONTH
PRIMARY
EFFICACY ENDPOINT ANTICIPATED IN JANUARY 2023
Source texT: (https://bit.ly/3UZbseD)
Further company coverage: VIVE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viveve Medical
See all newsU.S. STOCKS ON THE MOVE-Chord Energy, Kroger, PetMed Express
U.S. STOCKS ON THE MOVE-DoorDash, Walt Disney, Tesla
U.S. STOCKS ON THE MOVE-Papa John's, Whirlpool, Coca-Cola
Viveve Medical plunges as urinary disease drug fails to meet main goal
Brief: Viveve Medical Inc - Company Will Seek Strategic Alternatives And Will Be Delisted From Nasdaq